Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.

To evaluate the incidence and associated risk factors of massive subretinal hemorrhage (SRH) in patients with retinal angiomatous proliferation (RAP).A total of 187 eyes of 135 treatment-naıve patients diagnosed with RAP were evaluated retrospectively. Clinical records including the time between the...

Full description

Bibliographic Details
Main Authors: Jae Hyung Lee, Mee Yon Lee, Won Ki Lee
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5638495?pdf=render
_version_ 1818418253254361088
author Jae Hyung Lee
Mee Yon Lee
Won Ki Lee
author_facet Jae Hyung Lee
Mee Yon Lee
Won Ki Lee
author_sort Jae Hyung Lee
collection DOAJ
description To evaluate the incidence and associated risk factors of massive subretinal hemorrhage (SRH) in patients with retinal angiomatous proliferation (RAP).A total of 187 eyes of 135 treatment-naıve patients diagnosed with RAP were evaluated retrospectively. Clinical records including the time between the initial visit, last anti-vascular endothelial growth factor (VEGF) treatment, last stable examination, and the date of massive SRH were reviewed. Imaging findings including indocyanine green angiography (ICGA) and optical coherence tomography (OCT) were analyzed.Massive SRH developed in 18 eyes (9.6%) a median of 20 months after the initial presentation. Kaplan-Meier survival analysis revealed that the incidence (2.8, 5.8, 13.1, and 21.0% after 1,2,5 and 10 years, respectively) continuously increased. Among 14 eyes with discernable vascular anastomosis on baseline ICGA, 13 (92.8%) showed retinal arteriole involvement. On spectral-domain OCT imaging of the last visit prior to the massive SRH, a layered lamellar tissue complex was noted under the retinal pigment epithelium in 9 of 13 eyes, which was significantly associated with massive SRH[hazard ratio(HR),5.883;P = .010]. The average time between the last stable examination/last injection and the massive SRH was 2 and 5 months, respectively. The patients were treated with anti-VEGF, gas and recombinant tissue plasminogen activator injection; however, all except one eye had visual acuity worse than 20/1000 at the final visit.Massive SRH can occur in RAP in the course of anti-VEGF treatment, resulting in severe vision loss. A proactive dosing regimen may be more appropriate for these RAP eyes.
first_indexed 2024-12-14T12:19:44Z
format Article
id doaj.art-8cf51bba936941afad1560efa078f16a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T12:19:44Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8cf51bba936941afad1560efa078f16a2022-12-21T23:01:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-011210e018627210.1371/journal.pone.0186272Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.Jae Hyung LeeMee Yon LeeWon Ki LeeTo evaluate the incidence and associated risk factors of massive subretinal hemorrhage (SRH) in patients with retinal angiomatous proliferation (RAP).A total of 187 eyes of 135 treatment-naıve patients diagnosed with RAP were evaluated retrospectively. Clinical records including the time between the initial visit, last anti-vascular endothelial growth factor (VEGF) treatment, last stable examination, and the date of massive SRH were reviewed. Imaging findings including indocyanine green angiography (ICGA) and optical coherence tomography (OCT) were analyzed.Massive SRH developed in 18 eyes (9.6%) a median of 20 months after the initial presentation. Kaplan-Meier survival analysis revealed that the incidence (2.8, 5.8, 13.1, and 21.0% after 1,2,5 and 10 years, respectively) continuously increased. Among 14 eyes with discernable vascular anastomosis on baseline ICGA, 13 (92.8%) showed retinal arteriole involvement. On spectral-domain OCT imaging of the last visit prior to the massive SRH, a layered lamellar tissue complex was noted under the retinal pigment epithelium in 9 of 13 eyes, which was significantly associated with massive SRH[hazard ratio(HR),5.883;P = .010]. The average time between the last stable examination/last injection and the massive SRH was 2 and 5 months, respectively. The patients were treated with anti-VEGF, gas and recombinant tissue plasminogen activator injection; however, all except one eye had visual acuity worse than 20/1000 at the final visit.Massive SRH can occur in RAP in the course of anti-VEGF treatment, resulting in severe vision loss. A proactive dosing regimen may be more appropriate for these RAP eyes.http://europepmc.org/articles/PMC5638495?pdf=render
spellingShingle Jae Hyung Lee
Mee Yon Lee
Won Ki Lee
Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.
PLoS ONE
title Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.
title_full Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.
title_fullStr Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.
title_full_unstemmed Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.
title_short Incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation.
title_sort incidence and risk factors of massive subretinal hemorrhage in retinal angiomatous proliferation
url http://europepmc.org/articles/PMC5638495?pdf=render
work_keys_str_mv AT jaehyunglee incidenceandriskfactorsofmassivesubretinalhemorrhageinretinalangiomatousproliferation
AT meeyonlee incidenceandriskfactorsofmassivesubretinalhemorrhageinretinalangiomatousproliferation
AT wonkilee incidenceandriskfactorsofmassivesubretinalhemorrhageinretinalangiomatousproliferation